Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Merck
Baxter
Harvard Business School
McKinsey

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Bone Care International LLC v. Pentech Pharmaceuticals, Inc. (N.D. Ill. 2008)

See Plans and Pricing

« Back to Dashboard

Bone Care International LLC v. Pentech Pharmaceuticals, Inc. (N.D. Ill. 2008)

Docket   Start Trial Date Filed 2008-02-21
Court District Court, N.D. Illinois Date Terminated
Cause 35:271 Patent Infringement Assigned To Robert Michael Dow Jr.
Jury Demand Defendant Referred To Honorable Martin C. Ashman
Parties BONE CARE INTERNATIONAL LLC; COBREK PHARMACEUTICALS, INC.; GENZYME CORPORATION; PENTECH PHARMACEUTICALS, INC.
Patents 4,225,596; 4,391,802; 4,590,213; 4,626,549; 4,866,048; 5,602,116; 5,707,980; 6,126,920; 6,903,083; 7,078,058
Attorneys Brian J Sodikoff; Bruce Chasan; Christina Anne Larissa Schwarz; Christopher E. Loh; Craig M Kuchii; Daniel John Minion; Donald J. Curry; Filko Prugo; Fiona E. Darkin; James J. Kozuch; Jennifer Yule DePriest; John Wilkinson Kirkland , Iii; Kimberley A. Gavin; Mona Gupta; Raven Moore; Robert B. Breisblatt; Robert L. Baechtold; Robert S Silver; Robert W. Stevenson; Sarah R. Wolff; Scott K. Reed; Stephen P. Benson; William C. Youngblood; William J Castillo
Link to Docket External link to docket
Small Molecule Drugs cited in Bone Care International LLC v. Pentech Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Bone Care International LLC v. Pentech Pharmaceuticals, Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Bone Care International LLC v. Pentech Pharmaceuticals, Inc. (N.D. Ill. 2008)

Date Filed Document No. Description Snippet Link To Document
2009-02-02 108 memorandum opinion and order This case concerns U.S. Patents Nos. 5,602,116 and 6,903,083 directed to a method of treating…that the patents and technology at issue in the Connetics matters are not unrelated to the patents and technology…permitted. Pentech is the defendant in three patent infringement actions currently pending in this …available drugs. The Connetics matters concern U.S. Patents Nos. 6,126,920 and 7,078,058, directed to steroid… infringement and validity with respect to the patents-in-suit in those cases. II. Discussion External link to document
2009-05-06 149 text entry motions relate, at least in part, to U.S. Patent No. 6,903,083. At the 5/12/09 hearing on the joint motion…entry of the proposed consent judgment on the '083 patent would have on the motions to amend pleadings [110…21 February 2008 1:08-cv-01083 830 Patent Defendant District Court, N.D External link to document
2009-06-24 159 motion for sanctions Preparatiion, Filing and Prosecution of U.S. Patent 5,602,116 (Attachments: # 1 Memorandum of Law (Under… 21 February 2008 1:08-cv-01083 Patent Defendant District Court, N.D External link to document
2009-07-02 171 motion in limine Considerations on Non-Obviousness with Regard to U.S.Patent 5,602,116 (Attachments: # 1 Exhibit A, # 2 Exhibit B… 21 February 2008 1:08-cv-01083 Patent Defendant District Court, N.D External link to document
2009-07-09 176 response in opposition to motion of the non-obviousness of its U.S. Patent No. 5,602,116 (“‘116 patent”) or, alternately, to re-open fact…results with respect to Genzyme’s U.S. Patent No. 6,903,083 (“‘083 patent”) and copying with respect to both…connection with the ‘083 patent and copying with respect to the ‘083 and ‘116 patents in preparing for the…Secondary Considerations Explained A patent claim is invalid for obviousness: …subject matter sought to be patented and the prior art are such that the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Dow
Johnson and Johnson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.